BDC Healthcare Venture
18
19M
14
1.64
4
0.22
6
- Stages of investment
- Areas of investment
Summary
In 2011 was created BDC Healthcare Venture, which is appeared as Corporate Investor. The leading representative office of defined Corporate Investor is situated in the Montru00e9al. The venture was found in North America in Canada.
We also calculated 2 valuable employees in our database.
Among the various public portfolio startups of the fund, we may underline Clementia Pharmaceuticals, Repare Therapeutics, Thrasos We can highlight the next thriving fund investment areas, such as Medical, Therapeutics. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. The fund has specific favorite in a number of founders of portfolio startups. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Canada.
The standard case for the fund is to invest in rounds with 5 partakers. Despite the BDC Healthcare Venture, startups are often financed by Yaletown Partners, CTI Life Sciences Fund, BDC Venture Capital. The meaningful sponsors for the fund in investment in the same round are CTI Life Sciences Fund, Yaletown Partners, Fonds de solidaritu00e9 FTQ. In the next rounds fund is usually obtained by Yaletown Partners, Fonds de solidaritu00e9 FTQ, CTI Life Sciences Fund.
The fund is constantly included in 2-6 investment rounds annually. Considering the real fund results, this Corporate Investor is 3 percentage points more often commits exit comparing to other organizations. The important activity for fund was in 2015. Opposing the other organizations, this BDC Healthcare Venture works on 2 percentage points more the average amount of lead investments. Deals in the range of 10 - 50 millions dollars are the general things for fund. The top amount of exits for fund were in 2017.
Investments analytics
Analytics
- Total investments
- 18
- Lead investments
- 4
- Exits
- 6
- Rounds per year
- 1.64
- Follow on index
- 0.22
- Investments by industry
- Health Care (12)
- Biotechnology (11)
- Medical Device (7)
- Medical (6)
- Therapeutics (5) Show 17 more
- Investments by region
-
- Canada (17)
- United States (1)
- Peak activity year
- 2015
- Number of Unicorns
- 1
- Number of Decacorns
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 15
- Avg. valuation at time of investment
- 92M
- Group Appearance index
- 0.94
- Avg. company exit year
- 8
- Avg. multiplicator
- 8.51
- Strategy success index
- 0.40
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Fischer Block | 04 Sep 2018 | Energy, Predictive Analytics, Sensor | Early Stage Venture | 3M | United States, Pennsylvania |
Milestone Pharmaceuticals | 15 Jun 2015 | Biotechnology, Drug Discovery, Pharmaceuticals, Health Care, Therapeutics | Early Stage Venture | 17M | Quebec, Montreal, Canada |
Monteris Medical | 13 Nov 2014 | Health Care, Medical Device, Medical | Early Stage Venture | 30M | United States, Minnesota |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.